Gall Matthew (CIK 1816194) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-08-29). Recent activity: Sell ITOS (89,429 shares), Buy ITOS (24,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-29 | iTeos Therapeutics, Inc. (ITOS) | Chief Financial Officer | Sell | 89,429 | $0 |
| 2025-03-11 | iTeos Therapeutics, Inc. (ITOS) | Chief Financial Officer | Buy | 24,000 | $0 |
Source: SEC Form 4 filings · as of 2025-08-29